Hochman, M. J., Ruppert, A. S., Huang, Y., Mims, A., Borate, U., Swords, R., Traer, E., Baer, M. R., Duong, V. H., Stock, W., Odenike, T., Patel, P., Madanat, Y., Stein, E., Deininger, M. W., Schiller, G., Pollyea, D. A., Foran, J. M., Olin, R., Lin, T., Boyiadzis, M. M., Handa, S., Rueter, B., Gana, T. J., Heerema, N. A., Chen, T., Martycz, M., Stefanos, M., Marcus, S., Rosenberg, L., Druker, B., Levine, R., Burd, A., Yocum, A. O., Byrd, J. C. and Blum, W. (2020) “Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300627.